NO953548D0 - Immobilisering og separering av celler og andre partikler - Google Patents

Immobilisering og separering av celler og andre partikler

Info

Publication number
NO953548D0
NO953548D0 NO953548A NO953548A NO953548D0 NO 953548 D0 NO953548 D0 NO 953548D0 NO 953548 A NO953548 A NO 953548A NO 953548 A NO953548 A NO 953548A NO 953548 D0 NO953548 D0 NO 953548D0
Authority
NO
Norway
Prior art keywords
pct
immobilization
cells
date sep
particles
Prior art date
Application number
NO953548A
Other languages
English (en)
Other versions
NO953548L (no
Inventor
John Ugelstad
Per Stenstad
Lars Kilaas
Arvid Berge
Original Assignee
Sinvent As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinvent As filed Critical Sinvent As
Publication of NO953548D0 publication Critical patent/NO953548D0/no
Publication of NO953548L publication Critical patent/NO953548L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/5434—Magnetic particles using magnetic particle immunoreagent carriers which constitute new materials per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
    • G01N2446/90—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids characterised by small molecule linker used to couple immunoreagents to magnetic particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO953548A 1993-03-11 1995-09-08 Immobilisering og separering av celler og andre partikler NO953548L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939304979A GB9304979D0 (en) 1993-03-11 1993-03-11 Imobilisation and separation of cells and other particles
PCT/GB1994/000473 WO1994020858A1 (en) 1993-03-11 1994-03-10 Immobilisation and separation of cells and other particles

Publications (2)

Publication Number Publication Date
NO953548D0 true NO953548D0 (no) 1995-09-08
NO953548L NO953548L (no) 1995-11-08

Family

ID=10731857

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953548A NO953548L (no) 1993-03-11 1995-09-08 Immobilisering og separering av celler og andre partikler

Country Status (9)

Country Link
US (1) US5763203A (no)
EP (1) EP0688430B1 (no)
JP (1) JPH08507857A (no)
AT (1) ATE153767T1 (no)
CA (1) CA2158023A1 (no)
DE (1) DE69403460T2 (no)
GB (1) GB9304979D0 (no)
NO (1) NO953548L (no)
WO (1) WO1994020858A1 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646001A (en) * 1991-03-25 1997-07-08 Immunivest Corporation Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof
US5594111A (en) * 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexes for bioconjugate preparation
US5837878A (en) * 1994-01-28 1998-11-17 Prolinx, Inc. Boronic compound complexing reagents and highly stable complexes
US5594151A (en) * 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexing reagents derived from aminosalicylic acid
US5623055A (en) * 1994-01-28 1997-04-22 Prolinx, Inc. Phenylboronic acid complexes derived from aminosalicylic acid for bioconjugate preparation
US5847192A (en) * 1994-01-28 1998-12-08 Prolinx, Inc. Boronic compound complexing reagents and complexes
US5777148A (en) * 1994-01-28 1998-07-07 Prolinx, Inc. Boronic compound complexing reagents and highly stable complexes
US5744627A (en) * 1994-01-28 1998-04-28 Prolinx, Inc. Boronic compound complexing reagents and complexes
US5852178A (en) * 1994-01-28 1998-12-22 Prolinx, Inc. Phenylboronic acid complexing reagents for conjugating biologically active molecules
GB9417864D0 (en) * 1994-09-06 1994-10-26 Sinvent As Cell separation
US6919175B1 (en) 1995-04-01 2005-07-19 Roche Diagnostics Gmbh System for releasing and isolating nucleic acids
US6075126A (en) 1996-08-05 2000-06-13 Prolinx, Inc. Phenyldiboronic acid reagents and complexes
US6156884A (en) 1996-08-05 2000-12-05 Prolinx, Inc. Bifunctional boronic compound complexing reagents and complexes
WO1998043067A1 (en) * 1997-03-25 1998-10-01 Immunivest Corporation Apparatus and methods for capture and analysis of particulate entities
US5985658A (en) * 1997-11-14 1999-11-16 Health Research Incorporated Calmodulin-based cell separation technique
US20010049438A1 (en) * 1999-03-19 2001-12-06 Dix Connie Kim Purification of primer extension products
FR2817968B1 (fr) * 2000-12-07 2003-03-21 Bio Merieux Dispositif de capture d'une molecule cible
US7195923B2 (en) * 2001-01-31 2007-03-27 Scripps Laboratories, Inc. Ratiometric determination of glycated protein
US7285412B2 (en) * 2001-07-27 2007-10-23 Surface Logix Inc. Device for magnetic immobilization of cells
US7169577B2 (en) * 2001-07-27 2007-01-30 Surface Logix, Inc. Cell isolation and screening device and method of using same
US7169578B2 (en) * 2001-07-27 2007-01-30 Surface Logix, Inc. Cell isolation and screening device and method of using same
US7081489B2 (en) * 2001-08-09 2006-07-25 Florida State University Research Foundation Polymeric encapsulation of nanoparticles
US6989196B2 (en) * 2002-10-02 2006-01-24 Florida State University Research Foundation Microencapsulation of magnetic material using heat stabilization
US6964747B2 (en) * 2003-01-21 2005-11-15 Bioarray Solutions, Ltd. Production of dyed polymer microparticles
US7255895B2 (en) * 2003-01-21 2007-08-14 Bioarray Solutions, Ltd. Method for controlling solute loading of polymer microparticles
US20040157219A1 (en) * 2003-02-06 2004-08-12 Jianrong Lou Chemical treatment of biological samples for nucleic acid extraction and kits therefor
US7601491B2 (en) * 2003-02-06 2009-10-13 Becton, Dickinson And Company Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
ATE380343T1 (de) * 2003-07-17 2007-12-15 Invitrogen Dynal As Verfahren zur herstellung von ummantelten magnetischen teilchen
US20050239091A1 (en) * 2004-04-23 2005-10-27 Collis Matthew P Extraction of nucleic acids using small diameter magnetically-responsive particles
US7842281B2 (en) * 2004-05-10 2010-11-30 The Florida State University Research Foundation Magnetic particle composition for therapeutic hyperthermia
US20060024776A1 (en) * 2004-08-02 2006-02-02 Mcmillian Ray Magnetic particle capture of whole intact organisms from clinical samples
AU2005271687A1 (en) * 2004-08-03 2006-02-16 Becton, Dickinson And Company Use of magnetic material to fractionate samples
KR101230020B1 (ko) * 2004-10-12 2013-02-05 루미넥스 코포레이션 마이크로스피어의 표면 특성을 변경하는 방법
US20060234251A1 (en) * 2005-04-19 2006-10-19 Lumigen, Inc. Methods of enhancing isolation of RNA from biological samples
US8551780B2 (en) * 2008-02-01 2013-10-08 H. Lee Moffitt Cancer Center & Research Institute, Inc. Electroporation buffer composition and method of use
EP2194368B1 (de) 2008-12-03 2019-07-17 Grundfos Management A/S Sensorsystem zum Erfassen und Spezifizieren von einzelnen Partikeln in einem Fluid
JP5430463B2 (ja) * 2010-03-24 2014-02-26 メタウォーター株式会社 フローサイトメトリーによる微生物検出方法およびそれに用いる装置
JP5066615B2 (ja) 2011-01-31 2012-11-07 株式会社日立製作所 フェニルボロン酸基と特異的に結合するオリゴペプチド配列
US10240186B2 (en) 2011-07-14 2019-03-26 Fluxion Biosciences, Inc. Devices, systems, and methods for magnetic separation
SG11201407800SA (en) * 2012-05-31 2014-12-30 Agency Science Tech & Res Selective binding of biological targets to solid phase ureides
US10167502B2 (en) 2015-04-03 2019-01-01 Fluxion Biosciences, Inc. Molecular characterization of single cells and cell populations for non-invasive diagnostics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU530410B2 (en) * 1978-02-21 1983-07-14 Sintef Preparing aqueous emulsions
GB2024829B (en) * 1978-06-28 1982-08-04 Amicon Corp Method and product for separation of glycoproteins
NO155316C (no) * 1982-04-23 1987-03-11 Sintef Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
GB2181840B (en) * 1985-10-16 1989-11-29 Farmos Group Ltd Method for the immunoassay of a macromolecular analyte
CA1340927C (en) * 1987-10-09 2000-03-14 Peter S. Linsley Method for increasing the sensitivity of assays for target ligand
US5110745A (en) * 1989-06-01 1992-05-05 The Trustees Of The University Of Pennsylvania Methods of detecting glycated proteins

Also Published As

Publication number Publication date
ATE153767T1 (de) 1997-06-15
CA2158023A1 (en) 1994-09-15
NO953548L (no) 1995-11-08
DE69403460D1 (de) 1997-07-03
WO1994020858A1 (en) 1994-09-15
JPH08507857A (ja) 1996-08-20
DE69403460T2 (de) 1997-12-11
EP0688430B1 (en) 1997-05-28
EP0688430A1 (en) 1995-12-27
GB9304979D0 (en) 1993-04-28
US5763203A (en) 1998-06-09

Similar Documents

Publication Publication Date Title
NO953548D0 (no) Immobilisering og separering av celler og andre partikler
SE9003122D0 (sv) Improvement in solid phase binding assay
DE69115267D1 (de) Antigen-/antiantigenspaltung.
BR9106147A (pt) Granulos de pesticidas dispersaveis em agua ou soluveis em agua feitos a partir de ligantes termo-ativados
PL308109A1 (en) Improved method of detecting specific target cells among specialised or mixed populations of cells or in suspensions containing mixed populations of cells
ES8802089A1 (es) Metodo para determinar la presencia de uno o una pluralidad de analitos.
EP0117114A3 (en) Method and device for bacterial testing
ES8706964A1 (es) Un procedimiento para fraccionar anticuerpos de suero.
GR1002306B (el) Αναλυση και διαταξη συγκολλησεως στηλης.
AU1406195A (en) Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
DE69636564D1 (de) Verfahren zur freisetzung von magnetischen teilchen, die an zelloberflächen gebunden sind
EP1003552A4 (en) ANTIBODIES DIRECTED AGAINST LO-CD2a AND USE THEREOF TO INHIBIT THE ACTIVATION AND PROLIFERATION OF T-LYMPHOCYTES
AU4326693A (en) Monoclonal antibodies to glycoprotein p
GR3035226T3 (en) Immunoenzymatic conjugate, preparation method therefor and uses thereof
DE69527640D1 (de) Zusammensetzungen die gemischte transferrine als wirkstoff für induktion von immunotoleranz gegen antigen enthalten
GB2214295B (en) "hapten determination method, use and components"
ES8706445A1 (es) Un metodo en emparedado de doble anticuerpo para detectar o ensayar un antigeno seleccionado de urocinasa humana y un precursor de la misma
GR862335B (en) Method for utilizing cell lines which lack human class ii histocompatibility antigens
HK1021318A1 (en) Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation
DE3468324D1 (en) Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems
CA2148689A1 (en) Treatment of infertility and enhancement of fertilization capacity in mammalian males

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application